Science-driven, strategy-led.

Altaclara exists to make life-sciences market evolution easier to see and understand.

This free, non-commercial publication examines how markets form, compete, and grow across capital cycles, commercialization, regulation, adoption, market economics, and structural change.

My career began at the lab bench in cancer research, where curiosity about how science works became an interest in how innovation moves from discovery to market. Over the past 20 years, my work has spanned the full idea-to-market continuum, including global innovation and P&L leadership at Sartorius and MilliporeSigma.

That experience informs an end-to-end perspective on the decisions, trade-offs, and operating conditions that determine whether scientific promise becomes a sustainable business.

Altaclara synthesizes publicly available information, original analysis, and two decades of sector experience to connect signals often viewed separately.

Perfect information does not exist. No single signal explains a market. Insight comes from understanding how the pieces fit together and what they reveal about what comes next.

Helen Kim
Founder and Editor, Altaclara

Altaclara is an independent editorial publication. Its articles are analysis and commentary intended to inform discussion of life-sciences markets and innovation.

Altaclara does not provide company-specific advisory, implementation, investment, legal, financial, or medical advice.